Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4143940 | Anales de Pediatría | 2007 | 8 Pages |
Abstract
The efficacy of infliximab seems to differ considerably in the distinct types of inflammatory bowel disease and is practically null in indeterminate colitis. Randomized controlled studies in children are required to assess the exact efficacy of infliximab in our patients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
O. Segarra Cantón, D. Infante Pina, R. Tormo Carnicé,